G-CSF, rt-PA and combination therapy after experimental thromboembolic stroke

BACKGROUND: Granulocyte Colony-Stimulating Factor (G-CSF) has remarkable neuroprotective properties. Due to its proven safety profile, G-CSF is currently used in clinical stroke trials. As neuroprotectants are considered to be more effective in the early phase of cerebral ischemia and during reperfu...

Descripción completa

Detalles Bibliográficos
Autores principales: Kollmar, Rainer, Henninger, Nils, Urbanek, Christian, Schwab, Stefan
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2868804/
https://www.ncbi.nlm.nih.gov/pubmed/20388227
http://dx.doi.org/10.1186/2040-7378-2-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2868804/
https://www.ncbi.nlm.nih.gov/pubmed/20388227
http://dx.doi.org/10.1186/2040-7378-2-9

Ejemplares similares